Jonathan Allan - GENERAL COUNSEL & CORP SEC at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel & Corp Sec
Stock Symbol
STOK on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jonathan Allan - trading volume in the past year for Stoke Therapeutics, Inc.

Holdings reported by Jonathan Allan for Stoke Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 11.8K $297K $25.07 Oct 3, 2025 Direct
Restricted Stock Unit (RSU) 12.4K $149K $12.07 Dec 1, 2024 Direct Common Stock
Performance Stock Units 6K $72.4K $12.07 Aug 14, 2025 Direct Common Stock
Restricted Stock Units 48K $28.8K $0.60 Mar 20, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 72K Mar 20, 2025 Direct Common Stock
Stock Option (Right to Buy) 34.8K Oct 3, 2025 Direct Common Stock

Transactions reported by Jonathan Allan for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.